Creating a responsive IT infrastructure for managing global change within the pharmaceutical industry
by Hewlett-Packard Co.
The pharmaceutical industry is facing major hurdles in areas such as compliance and drug development. One example: 2003 marked the lowest rate of U.S. Food and Drug Administration (FDA) drug approvals in 20 years. To be successful, drug companies must respond by accelerating and increasing drug development, lowering operational costs and testing more new drugs. They must take steps to ensure they can adapt quickly and efficiently to other critical needs facing the business. In this white paper, HP describes its OpenView Management Solutions for the Adaptive Enterprise, which enables FDA compliance, increases application and network availability and maximizes the value of business processes while lowering operational costs.
Achieving cost-effective FDA compliance is one of the industry's most significant challenges. Stringent regulatory guidelines have forced enterprises to adopt new strategies and information technology tools, especially around change management.
| Published: | 2004 |
| Format: | |
| Length: | 8 pages |
| Type: | White paper |
| Language: | English |
.
SPONSORED REPORTS
